Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperplasia of Mammary Glands”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06195306
What this trial is testing

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT05810025
What this trial is testing

FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments

Who this might be right for
Breast Cancer
Columbia University 70
Not applicableStudy completedNCT01975363
What this trial is testing

Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBRCA1 Gene MutationBRCA2 Gene Mutation+2 more
Ohio State University Comprehensive Cancer Center 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07499999
What this trial is testing

Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast CancerDuctal CarcinomaEstrogen-receptor-positive Breast Cancer+4 more
Dana-Farber Cancer Institute 140
Not applicableStudy completedNCT01925586
What this trial is testing

Atypical Lesions of the Breast: Close Observation Versus Excision (ALCOVE)

Who this might be right for
Atypical Ductal Hyperplasia (ADH) of the Breast
Yale University 9
Testing effectiveness (Phase 2)Study completedNCT02928978
What this trial is testing

Ruxolitinib for Premalignant Breast Disease

Who this might be right for
Ductal Carcinoma In SituAtypical Lobular HyperplasiaAtypical Ductal Hyperplasia+1 more
Julie Nangia 84
Post-approval studies (Phase 4)UnknownNCT02929420
What this trial is testing

A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule

Who this might be right for
Fibrocystic Disease of Breast
First Affiliated Hospital Xi'an Jiaotong University 600
Not applicableLooking for participantsNCT05178498
What this trial is testing

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+2 more
Ohio State University Comprehensive Cancer Center 960
Testing effectiveness (Phase 2)UnknownNCT04767620
What this trial is testing

Clinical Trial of Ruxian Zengsheng No. 1 Decoction

Who this might be right for
Mammary Gland Hyperplasia
Jiuda Zhao 137
Not applicableStudy completedNCT00627276
What this trial is testing

Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia

Who this might be right for
Breast CancerPrecancerous Condition
OHSU Knight Cancer Institute 16
Not applicableEnded earlyNCT00794989
What this trial is testing

Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer

Who this might be right for
Breast CancerPrecancerous Condition
Roswell Park Cancer Institute 20
Not applicableUnknownNCT02505256
What this trial is testing

Study Into Treatment of Hyperplasia of Mammary Glands

Who this might be right for
Hyperplasia
Shandong University 5,000